ORBIMED ADVISORS LLC

Average Profitability
1.61%
Insider Buys Quantity
102
Insider Buys Sum
$601.79M
Insider Sells Quantity
199
Insider Sells Sum
$1.39B

Insider Activity of ORBIMED ADVISORS LLC

According to the SEC Form 4 filings, ORBIMED ADVISORS LLC, being in a position of

  1. at Adicet Bio, Inc.,
    оver the last 12 months, has bought 3125000 shares for $7.5M, and sold 0 shares,
    over all time since 2018-01-30, has bought 5066666 shares for $25.33M, and sold 0 shares.

The largest purchase of all time was on 2020-09-25 and amounted to 2473600 shares of Prelude Therapeutics Incorporated for $47M.

The largest sale of all time was on 2021-03-01 and amounted to 1220000 shares of SpringWorks Therapeutics, Inc. for $101.49M.

Biography of ORBIMED ADVISORS LLC

No biography is available at this moment.

2024-12-11SalePassage Bio, Inc.
PASG
10 percent owner
80
0.0001%
$0.80$64-8.15%
2024-12-10SalePassage Bio, Inc.
PASG
10 percent owner
8,015
0.013%
$0.80$6,412-8.9%
2024-12-09SalePassage Bio, Inc.
PASG
10 percent owner
54,181
0.0924%
$0.84$45,512-7.5%
2024-12-06SalePassage Bio, Inc.
PASG
10 percent owner
20,903
0.0352%
$0.82$17,140-2.19%
2024-12-04SalePassage Bio, Inc.
PASG
10 percent owner
76,200
0.1269%
$0.79$60,198+1.28%
2024-09-19SalePassage Bio, Inc.
PASG
10 percent owner
39,300
0.0645%
$0.71$27,903-7.42%
2024-09-18SalePassage Bio, Inc.
PASG
10 percent owner
25,631
0.0432%
$0.73$18,711-7.55%
2024-09-17SalePassage Bio, Inc.
PASG
10 percent owner
111,400
0.181%
$0.73$81,322-10.82%
2024-09-16SalePassage Bio, Inc.
PASG
10 percent owner
63,100
0.1035%
$0.74$46,694-11.17%
2024-08-26SaleARS Pharmaceuticals, Inc.
SPRY
director
83,695
0.0772%
$13.00$1.09M+6.21%
2024-08-23SaleARS Pharmaceuticals, Inc.
SPRY
director
69,500
0.0642%
$13.03$905,585+8.14%
2024-08-22SaleARS Pharmaceuticals, Inc.
SPRY
director
391,482
0.3592%
$12.94$5.07M+9.37%
2024-08-21SaleARS Pharmaceuticals, Inc.
SPRY
director
407,700
0.3919%
$13.56$5.53M+4.51%
2024-08-13SaleKeros Therapeutics, Inc.
KROS
director
250,000
0.6566%
$44.01$11M0%
2024-08-13PurchasescPharmaceuticals Inc.
SCPH
10 percent owner
500,000
1.2438%
$4.00$2M0%
2024-07-16SaleTerns Pharmaceuticals, Inc.
TERN
5,188
0.012%
$10.00$51,880-23.09%
2024-07-15SaleTerns Pharmaceuticals, Inc.
TERN
50,976
0.1182%
$10.00$509,7600%
2024-07-02SaleTELA Bio, Inc.
TELA
10 percent owner
36,600
0.1299%
$4.54$166,1640%
2024-07-01SaleTELA Bio, Inc.
TELA
10 percent owner
13,700
0.0501%
$4.68$64,1160%
2024-06-28SaleTELA Bio, Inc.
TELA
10 percent owner
378,000
1.4002%
$4.74$1.79M0%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.